57939-09-0

Basic information

• Product Name: 4-phenoxy-3-(piperidin-1-yl)-5-sulfamoylbenzoic acid
• Synonyms: 4-phenoxy-3-(piperidin-1-yl)-5-sulfamoylbenzoic acid
• CAS NO: 57939-09-0
• Molecular Weight: 376.433
• Mol File: 57939-09-0.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 4-phenoxy-3-(piperidin-1-yl)-5-sulfamoylbenzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-phenoxy-3-(piperidin-1-yl)-5-sulfamoylbenzoic acid(57939-09-0)
• EPA Substance Registry System: 4-phenoxy-3-(piperidin-1-yl)-5-sulfamoylbenzoic acid(57939-09-0)

Safety Data

• Hazardous Substances Data: 57939-09-0(Hazardous Substances Data)

Upstream product

• 108-95-2 phenol 
• 22892-96-2 4-chloro-3-nitro-5-sulfamoylbenzoic acid 
• 28328-53-2 3-nitro-4-phenoxy-5-sulfamoylbenzoic acid 
• 57939-04-5 3-nitro-4-phenoxy-5-sulfamoylbenzoic acid methyl ester 
• 60376-73-0 3-(dimethylaminomethylenesulfamoyl)-5-nitro-4-phenoxybenzoic acid methyl ester 
• 60376-74-1 5-amino-3-(dimethylaminomethylenesulfamoyl)-4-phenoxybenzoic acid methyl ester 
• 1431505-42-8 methyl 3-(N-((dimethylamino)methylene)sulfamoyl)-4-phenoxy-5-(piperidin-1-yl)benzoate 

Downstream Products

• 1431501-29-9 C₂₂H₂₈N₂O₅S 

Relevant articles and documents

2,3,5 TRISUBSTITUTED ARYL AND HETEROARYL AMINO DERIVATIVES, COMPOSITIONS, AND METHODS OF USE

Compounds are disclosed that have a formula represented by the following:(I) wherein Cy, L1 R1, R2a, R2b, R3, R4, n, and L2 are as described herein. These compounds may be prepared as a pharmaceutical composition, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example addictive disorders, Alzheimer's Disease, anxiety disorders, ascites, autism, bipolar disorder, cancer, depression, endothelial corneal dystrophy, edema, epilepsy, glaucoma, Huntington's Disease, inflammatory pain, insomnia, ischemia, migraine, migraine with aura, migraine without aura, neuropathic pain, nociceptive neuralgia, nociceptive pain, ocular diseases, pain, itch, excessive itch, Pruritis, neuropathic pruritis, Parkinson's disease, personality disorders, postherpetic neuralgia, psychosis, schizophrenia, seizure disorders, tinnitus, and withdrawal syndromes.

5-Sulfamoylbenzoic acid derivatives carrying a heterocyclic substituent

5-Sulfamoylbenzoic acids substituted in 4-position by various substituents and in 3-position by a cyclic amino group having sali-diurectic properties, and a process for their manufacture.